InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Doogan Declan, Director. Insider active across 2 companies, notably Tenax Therapeutics, INC.. In total, 7 disclosures have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €2.1m. Activity tracked since 30 June 2021. The latest transaction was disclosed on 11 August 2022 (Don). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Doogan Declan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
567,871 shares0Common StockSEC:0001654954-22-011198:0
2,464 shares@ US$67.82740.011% mcap3.3% of flowCommon SharesSEC:0001562180-22-001435:0
11,706 shares@ US$64.42210.051% mcap14.9% of flowCommon SharesSEC:0001562180-22-001434:0
13,026 shares@ US$112.399690.6% of flowCommon SharesSEC:0001562180-21-007370:0
250,000 shares@ US$0.619.4% of flowCommon SharesSEC:0001562180-21-007138:0
567,871 shares0Common StockSEC:0001654954-21-008766:0
3,070,000 sharesCommon StockSEC:0001654954-21-006925:0
7 of 7 declarations
About Doogan Declan
Declan Doogan serves as a Director at TENAX THERAPEUTICS, INC. and Biohaven Pharmaceutical Holding Co Ltd. He brings his expertise in corporate governance and strategy, contributing to the oversight and direction of these companies' activities. His experience in the pharmaceutical sector enables him to play a crucial role in strategic decision-making.
